期刊文献+

Fibroscan定量评价非酒精性脂肪肝合并HBV感染临床研究

Clinical study on quantitatively evaluating fatty liver with HBV infection by fibroscan
原文传递
导出
摘要 目的研究乙型肝炎病毒(HBV)病毒载量、肝脏硬度值(LSM)等对受控衰减参数(CAP)的影响。方法收录我院2015年1月~2017年4月诊断为HBV感染合并非酒精性脂肪肝患者443例。统计项目包括瞬时弹性成像技术(Fibroscan)检查结果 CAP和LSM、性别、年龄、谷丙转氨酶(ALT)、谷丙转氨酶(AST)、乙型肝炎病毒载量(HBV-DNA)等。所有数据应用SPSS17.0软件进行分析。结果 LSM,ALT,AST,HBV-DNA与CAP进行线性回归分析,LSM对CAP有显著影响(P<0.05),肝脏炎症程度ALT,AST及HBV-DNA高低对CAP无显著影响(P均>0.05)。结论转氨酶(ALT,AST),HBV-DNA对CAP测量无显著影响,LSM对CAP指标有显著影响。 Objective To study the influence of HBV viral load and liver hardness value( LSM) on controlled attenuation parameters( CAP). Methods Four hundred and forty-three cases of HBV infection and non-alcoholic fatty liver disease diagnosed in our hospital from January 2015 to April 2017 were included. Statistical items: Transient Elastic Imaging technique: CAP and LSM,gender,age,alanine transaminase( ALT),glutamate transaminase( AST),hbv-dna( HDA),etc. All datas were analyzed by SPSS17. 0 software. Results LSM,ALT,AST,hbv-dna and CAP were linear regression analysis. LSM had a significant effect on CAP( P〈0. 05),and there was no significant effect of ALT,AST and hbv-dna on the level of liver inflammation( P = 0. 72,0. 54,0. 10〉0. 05). Conclusion Aminotransferase( ALT,AST) and HBV-DNA had no significant effect on CAP measurement. LSM has significant influence on CAP index.
作者 张晴晴 邱淑玉 杨娜娜 闫振武 ZHANG Qingqing;QIU Shuyu;YANG Nana;YAN Zhenwu(Department of Epidemiology,Weifang Medical University,Weifang 261053,China;Department of Infection Diseases,Weifang People's Hospital)
出处 《潍坊医学院学报》 2018年第2期91-93,共3页 Acta Academiae Medicinae Weifang
关键词 非酒精性脂肪性肝病 乙型肝炎病毒感染 瞬时弹性成像技术 Non-alcoholic fatty liver disease Hepatitis B virus infection Instantaneous elastic imaging technology
  • 相关文献

参考文献2

二级参考文献14

  • 1Giovanna Ferraioli,Carmine Tinelli,Barbara Dal Bello,Mabel Zicchetti,Raffaella Lissandrin,Gaetano Filice,Carlo Filice,Elisabetta Above,Giorgio Barbarini,Enrico Brunetti,Willy Calderon,Marta Di Gregorio,Roberto Gulminetti,Paolo Lanzarini,Serena Ludovisi,Laura Maiocchi,Antonello Malfitano,Giuseppe Michelone,Lorenzo Minoli,Mario Mondelli,Stefano Novati,Savino FA Patruno,Alessandro Perretti,Gianluigi Poma,Paolo Sacchi,Domenico Zanaboni,Marco Zaramella.Performance of liver stiffness measurements by transient elastography in chronic hepatitis[J].World Journal of Gastroenterology,2013,19(1):49-56. 被引量:18
  • 2Beom Kyung Kim,James Fung,Man-Fung Yuen,Seung Up Kim.Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives[J].World Journal of Gastroenterology,2013,19(12):1890-1900. 被引量:15
  • 3Giada Sebastiani,Alfredo Alberti.Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy[J].World Journal of Gastroenterology,2006,12(23):3682-3694. 被引量:33
  • 4Martin Blachier,Henri Leleu,Markus Peck-Radosavljevic,Dominique-Charles Valla,Fran?oise Roudot-Thoraval.The burden of liver disease in Europe: A review of available epidemiological data[J].Journal of Hepatology.2013(3)
  • 5Robert P. Myers,Aaron Pollett,Richard Kirsch,Gilles Pomier‐Layrargues,Melanie Beaton,Mark Levstik,Andres Duarte‐Rojo,David Wong,Pam Crotty,Magdy Elkashab.Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography[J].Liver Int.2012(6)
  • 6Manoj Kumar,Archana Rastogi,Tarandeep Singh,Chhagan Behari,Ekta Gupta,Hitendra Garg,Ramesh Kumar,Vikram Bhatia,Shiv K Sarin.Controlled attenuation parameter for non‐invasive assessment of hepatic steatosis: Does etiology affect performance?[J].J Gastroenterol Hepatol.2013(7)
  • 7Vincent Wai-Sun Wong,Grace Lai-Hung Wong,Winnie Chiu-Wing Chu,Angel Mei-Ling Chim,Arlinking Ong,David Ka-Wai Yeung,Karen Kar-Lum Yiu,Shirley Ho-Ting Chu,Hoi-Yun Chan,Jean Woo,Francis Ka-Leung Chan,Henry Lik-Yuen Chan.Hepatitis B virus infection and fatty liver in the general population[J].Journal of Hepatology.2011(3)
  • 8M. Sasso,V. Miette,L. Sandrin,M. Beaugrand.The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan ?[J].Clinics and Research in Hepatology and Gastroenterology.2011(1)
  • 9Tomoko Hatta,Yasunari Fujinaga,Masumi Kadoya,Hitoshi Ueda,Hiroaki Murayama,Masahiro Kurozumi,Kazuhiko Ueda,Michiharu Komatsu,Tadanobu Nagaya,Satoru Joshita,Ryo Kodama,Eiji Tanaka,Tsuyoshi Uehara,Kenji Sano,Naoki Tanaka.Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease[J].Journal of Gastroenterology.2010(12)
  • 10Magali Sasso,Michel Beaugrand,Victor de Ledinghen,Catherine Douvin,Patrick Marcellin,Raoul Poupon,Laurent Sandrin,Véronique Miette.Controlled Attenuation Parameter (CAP): A Novel VCTE? Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes[J].Ultrasound in Medicine & Biology.2010(11)

共引文献231

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部